Home » Topics » BioWorld Science

BioWorld Science
RSS

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

AtheroGenics files IND for intravenous AGIX-4207 to treat RA

Sep. 4, 2001

Study investigates Toprol-XL for reversal of cardiac remodeling

Sep. 4, 2001

Samaritan's Anticort completes phase Ib/IIa clinical trial for HIV infection

Sep. 4, 2001

Physiome Sciences licenses PathwayPrism technology to 3rd Millennium

Sep. 4, 2001

Cephalon reports changes in Gabitril product name

Sep. 4, 2001

Eisai describes new neovascularization inhibitors in patent literature

Sep. 3, 2001

Dipeptide HIV protease inhibitors in development at Japan Energy

Sep. 3, 2001

Safe and effective glucose-lowering agents prepared at Kyowa Hakko

Sep. 3, 2001

Sanofi-Synthelabo claims new series of beta3-adrenoceptor agonists

Sep. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...